Fundraising FoxaMoon — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Character Bio is a patient-driven therapeutics company that combines genomics, longitudinal clinical and imaging data, and machine learning to identify genetic drivers of disease progression and develop new treatments, with a focus on polygenic diseases.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(CEO, Co-Founder)inMarcel van der Brug(Scientific Advisor, Co-Founder)inNick Johnson(Technology Advisor, Co-Founder)inDaniel Elgort(Chief Data and Analytics Officer)inLaura Carter(Chief Scientific Officer)inRobert Kim(Chief Medical Officer)in
Co-investorsLuma GroupSanofi VenturesInnovation EndeavorsCantos VenturesCatalio Capital Management, LPDuke Capital Partners+5 more
Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.
BiotechHealthtechMedical DevicesElkins Park, US
Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))inMichael Haydin(Executive Officer)
BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in
Co-investorsVisionary VenturesCanaan PartnersCivilization Ventures Management, LlcFemHealth VenturesJSD Capital, LLCUS Venture Partners
Lin Health provides virtual, evidence-based behavioral healthcare for people with chronic pain, using the Collaborative Care model and a technology platform to address the underlying causes of pain rather than only symptoms.
Digital HealthHealthtechMental HealthWellness & Fitness
Yehuda Kogan(Founder)in
Co-investorsLIP Ventures BoutiqueSaban VenturesShoni Health VenturesViola VenturesMayo Clinic VenturesOsage Venture Partners+1 more
Plexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.
AI & Machine LearningBiotechDeep TechSan Diego, US
Michael Martin, Ph.D.(Chief Executive Officer, President)Jorge F. DiMartinoinMichael Martin(President, Chief Executive Officer)inStephen Mullennix(Executive Officer)inSerge Messerlian, M.Sc., M.B.A.(Chief Executive Officer)
BoardSerge Messerlian(Director)in
Co-investorsCRV (Charles River Ventures)DCVC (Data Collective)M VenturesNeotribe VenturesPivotal Life SciencesSoftBank Vision Fund+3 more
Positive Development provides autism therapy and developmental care services for neurodivergent children and their families.
Digital HealthHealthtechMedical DevicesMental HealthMclean, US
Mike Suiters(Executive Officer, Director)inNick Whitehead(Director)in
BoardAdam Seabrook(Director)inDaniel Gebremedhin(Director)John Banta(Director)inBrenton Fargnoli(Director)in
Co-investorsAlleyCorpB Capital GroupB4 CapitalFlare Capital PartnersLifeforce CapitalObvious Ventures+3 more
.jpeg){kind=logo}
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.